Align Technology Inc
0HCK.L
$133.59 3.80%
Exchange: LSE | Sector: Healthcare | Industry: Medical Equipment Services
Q2 2024
Published: Aug 2, 2024

Earnings Highlights

  • Revenue of $1.03B up 2.6% year-over-year
  • EPS of $1.28 decreased by 12.3% from previous year
  • Gross margin of 70.3%
  • Net income of 96.56M
  • ""While our revenue continues to grow, we're facing pressure on margin due to increased operational costs and supply chain disruptions."" - Joseph Hogan, CEO

Align Technology Inc (0HCK.L) Q2 2024 Financial Results: Short-term Challenges amid Long-term Growth

Executive Summary

In Q2 2024, Align Technology Inc reported a revenue of $1.028 billion, representing a 2.63% increase year-over-year (YoY) and a 3.11% increase quarter-over-quarter (QoQ). However, the company faced a significant decline in profitability metrics, with net income dropping by 13.64% YoY to $96.6 million and a 14.47% decrease in operating income, reflecting challenges in cost management amidst revenue growth. Management notes that challenges in supply chain constraints and competition are impacting overall profitability but emphasizes ongoing investments in technology and product development as key drivers for long-term growth.

Key Performance Indicators

Revenue

1.03B
QoQ: 3.11% | YoY:2.63%

Gross Profit

722.63M
70.26% margin
QoQ: 2.75% | YoY:1.26%

Operating Income

147.05M
QoQ: -4.60% | YoY:-14.47%

Net Income

96.56M
QoQ: -8.06% | YoY:-13.64%

EPS

1.28
QoQ: -8.57% | YoY:-12.33%

Revenue Trend

Margin Analysis

Key Insights

  • **Q2 2024 Revenue**: $1.028 billion (YoY: +2.63%, QoQ: +3.11%)
  • **Gross Profit**: $722.6 million (Gross Margin: 70.26%, YoY: +1.26%, QoQ: +2.75%)
  • **Operating Income**: $147.0 million (Operating Margin: 14.30%, YoY: -14.47%, QoQ: -4.60%)
  • **Net Income**: $96.6 million (Net Margin: 9.39%, YoY: -13.64%, QoQ: -8.06%)
  • **EPS**: $1.28 (YoY: -12.33%, QoQ: -8.57%)

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q2 2025 1,012.45 1.72 -1.6% View
Q1 2025 979.26 1.27 -1.8% View
Q4 2024 995.22 1.39 +4.0% View
Q3 2024 977.87 1.55 +1.8% View
Q2 2024 1,028.49 1.28 +2.6% View